FindTrial
Sign In

Prognostic factors of locally advanced or advanced pancreatic cancer: a retrospective analysis

Prognostic factors of locally advanced or advanced pancreatic cancer: a retrospective analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100051511
Enrollment
Unknown
Registered
2021-09-25
Start date
2021-09-13
Completion date
Unknown
Last updated
2022-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

Case series:No

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. For patients with locally advanced or advanced pancreatic cancer confirmed by pathology, the diagnosis should be combined with pathology and imaging (CT or MRI) to make a comprehensive judgment; 2. Age 18 or above, gender is not limited; 3. Received at least 1 cycle of anti-tumor therapy (chemotherapy, radiotherapy, targeted therapy, immunotherapy, etc.).

Exclusion criteria

Exclusion criteria: 1. Incomplete clinical data (including medical records, imaging examinations, etc.); 2. Those with incomplete survival data.

Design outcomes

Primary

MeasureTime frame
Nutritional Risk Screening - 2002;Patient subjective global assessment;prognostic nutritional index;Pain digital assessment;Neutrophil/lymphocyte ratio;Platelet/lymphocyte ratio;Lymphocyte/Monocyte Ratio;C-reactive protein/albumin ratio;—

Countries

China

Contacts

Public ContactCao Dan

West China Hospital, Sichuan University

caodan@scu.edu.cn+86 18980605963

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026